PExA AB
PExA develops non-invasive technology for respiratory biomarker discovery.
Yleiskatsaus
- 5–9
- Työntekijät
- 500–749t SEK
- Liikevaihto
- 2014
- Perustettu
Kuvaus
PExA develops and commercializes a unique technology aimed at discovering early biomarkers in the field of respiratory medicine. Their core offering is a non-invasive method for sampling Respiratory Tract Lining Fluid (RTLF) derived from particles collected in exhaled air. This technique provides re...